Sanofi CEO: Making drug data public could hurt investment in EU

06/24/2013 | Reuters

The European Medicines Agency's publication of a draft policy that would make detailed data on drugs publicly available after they are approved could deter crucial investment in Europe, said Chris Viehbacher, CEO of Sanofi and president of the European Federation of Pharmaceutical Industries and Associations. The Pharmaceutical Research and Manufacturers of America has condemned EMA's plans to unveil clinical-trial information, saying it could weaken research incentives and harm business.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD